# FDA Inspection 1231973 - Biomat USA, Inc. - February 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/46f50d85-82e4-4e99-abaf-ede5baa12f4f
Source feed: FDA_Inspections

> FDA Inspection 1231973 for Biomat USA, Inc. on February 22, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231973
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-02-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1170093 - 2022-05-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5e2dd834-2434-4ebc-b8bd-4928554989b4)
- [FDA Inspection 1170093 - 2022-05-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b2d2b9ac-33ea-4ac8-ad56-818c40841c43)
- [FDA Inspection 1029116 - 2017-08-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f56b2162-cc54-4b3d-b8c8-735c6a6e5873)
- [FDA Inspection 822777 - 2013-03-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/be55dc6f-98e8-41eb-9721-94d92de580b7)
- [FDA Inspection 736171 - 2011-07-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d00e3aaa-b79a-4f5e-b0e9-fde0a1c64dd9)

Company: https://www.keypedia.com/companies/biomat-usa-inc/9a1c1321-c355-48e8-908c-0e5e5f00108c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d